J0593
HCPCSInj., lanadelumab-flyo, 1 mg
Official HCPCS Level II long descriptor
Injection, lanadelumab-flyo, 1 mg (code may be used for medicare when drug administered under direct supervision of a physician, not for use when drug is self-administered)
HCPCS Level II code J0593 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj., lanadelumab-flyo, 1 mg
Added to HCPCS: 2019-10-01
Nearby codes in J0
- J0584Injection, burosumab-twza 1m
- J0585Injection,onabotulinumtoxina
- J0586Abobotulinumtoxina
- J0587Inj, rimabotulinumtoxinb
- J0588Incobotulinumtoxin a
- J0589Inj daxibotulinumtoxina-lanm
- J0591Inj deoxycholic acid, 1 mg
- J0592Buprenorphine hydrochloride
- J0594Busulfan injection
- J0595Butorphanol tartrate 1 mg
- J0596Injection, ruconest
- J0597C-1 esterase, berinert
- J0598C-1 esterase, cinryze
- J0599Inj., haegarda 10 units
- J0600Edetate calcium disodium inj
- J0601Sevelamer carbonate 20 mg
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.